MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Business Announcement
Updates every hour. Last Updated: 13-Oct-2025 11:11 ET (13-Oct-2025 15:11 GMT/UTC)